How much is Mineralys worth in 2026?

Mineralys has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Mineralys raised?

Mineralys has raised N/A in total funding across 2 funding rounds.

Mineralys

Drug Discovery

Mineralys valuation and funding history | Last updated: February 13, 2024 | 2 funding rounds

Current Valuation

N/A

As of February 13, 2024

Total Funding Raised

N/A

Across 2 rounds

Last Round

PIPE

$120.0M

Last Funding

Feb 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 13, 2024	PIPE	$120.0M	N/A	-
June 1, 2022	Early Stage VC (Series B)	$118.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Mineralys is currently valued at N/A as of February 13, 2024.

Track Mineralys Valuation Updates

Get notified when Mineralys raises new funding or valuation changes

Explore More Data

Detailed analysis for Mineralys

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Mineralys's valuation history, funding rounds, and growth metrics.

No credit card required

What is Mineralys Worth in 2026?

Mineralys is a leading private company in the Drug Discovery sector. Track Mineralys's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Mineralys Valuation is Determined

Private company valuations like Mineralys's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.